Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.

Anna Rita BiliaMaria Camilla BergonziBenedetta IsacchiEmiliano AntigaMarzia Caproni

Published in: The Journal of pharmacy and pharmacology (2018)

Curcumin nanoparticles represent an effective adjuvant therapy in moderate-to-severe psoriasis patients treated with oral acitretin, improving their lipid serum profile.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
high intensity
early onset
systematic review
prognostic factors
peritoneal dialysis
atopic dermatitis
drug induced
walled carbon nanotubes